Diabetes care improves when support adapts to real-life changes, removing barriers and sustaining daily habits beyond reminders, education, and one-time interventions. Imagine a woman who picks up her ...

Regulatory clearance includes Guardant360 CDx to select patients with ESR1 mutations for imlunestrant plus abemaciclib in ER+/HER2– advanced disease after endocrine-therapy progression. Phase 3 ...

What the Data Show," Dr. Vaduganathan walks through the cardiovascular outcomes trials that built the evidence base for SGLT2 i ...

Three machine learning models trained to predict recurrent autoimmune hepatitis after liver transplantation were all outperformed by ordinary logistic regression, which reached an ...

In the phase 4 IMMpactful trial, 57.3% of biologic-naive adults with moderate psoriasis reached PASI 90 on risankizumab at week 16 against 22.9% on deucravacitinib, a gap of more than 34 percentage ...

This year’s World Alzheimer’s Day theme is “The Earlier You Know, The More You Can Do: A Dementia Diagnosis Matters,” observed September 21, 2026, bringing attention to the disease and the importance ...

Seven attributes significantly influenced choices; importance ranked itch (22%) and appearance (21%) above cancer (16%), infection (14%), pain (13%), administration (7%), and major heart problems (6%) ...

The FDA approved rebisufligene etisparvovec-hopf (Fayuvi; Ultragenyx), also known as UX111, last week, on September 17, making it the first FDA-approved treatment for pediatric patients with ...

Population Health, Equity & Outcomes is a quarterly publication dedicated to providing a platform for the exchange of research, policy analysis, and insights that aim to improve health outcomes and ...